220153-09-3

Upstream product

• 173911-76-7 methyl (Z)-2-O-benzyl-3,4-di-O-(p-methoxybenzyl)-6-O-acetyl-α-D-glucos-5-enopyranoside 
• 173911-77-8 (1R,2R,3S,4R,5S)-3-benzyloxy-2-hydroxy-4,5-bis(4-methoxybenzyloxy)-6-oxocyclohexyl acetate 
• 173672-84-9 D-1-O-acetyl-3-O-benzyl-2,6-di-O-benzyloxymethyl-4,5-di-O-methoxy-benzyl-myo-inositol 
• 173672-85-0 D-3-O-benzyl-2,6-di-O-benzyloxymethyl-4,5-di-O-methoxybenzyl-myo-inositol 
• 173672-83-8 1-O-acetyl-3-O-benzyl-4,5-di-O-(p-methoxybenzyl)-myo-inositol 
• 3587-60-8 Benzyloxymethyl chloride 
• 220153-08-2 (+)-D-3-O-benzyl-2,6-O-bisbenzyloxymethyl-myo-inositol 

Downstream Products

• 2068-89-5 D-myo-inositol 1,4,5-triphosphate 

Relevant academic research and scientific papers

Novel synthesis of enantiomerically pure natural inositols and their diastereomers

A novel synthesis of all stereoisomers of natural inositols has been developed. The key strategy is the stereoselective reduction of substituted β-hydroxy cyclohexanones which are prepared from a variety of 6-O-acetyl 5- enopyranosides via Ferrier-II reaction catalyzed by palladium chloride. The utility of this approach is demonstrated by the synthesis of D-myo-inositol 1,4,5-tris(phosphate)(IP3).